EverSource Wealth Advisors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.02K Buy
1,394
+343
+33% +$1.5K ﹤0.01% 3196
2026
Q1
$4.04K Buy
1,051
+801
+320% +$3.28K ﹤0.01% 3358
2025
Q4
$927 Buy
250
+206
+468% +$1.77K ﹤0.01% 3726
2025
Q3
$621 Buy
+44
New +$686 ﹤0.01% 3891
2024
Q3
Sell
-16
Closed -$852 3094
2024
Q2
$852 Buy
16
+1
+7% +$49 ﹤0.01% 2771
2024
Q1
$567 Hold
15
﹤0.01% 2685
2023
Q4
$1.21K Buy
+15
New +$1.22K ﹤0.01% 2334

Other funds holding OM

EverSource Wealth Advisors's OM Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Outset Medical (OM) stake by 33% in Q2 2026, buying an estimated $1.5K and bringing the position to 1,394 shares worth $6.02K. The position accounts for ﹤0.01% of the portfolio, ranked #3196.

EverSource Wealth Advisors first reported a position in OM in Q4 2023 and has held it in 7 quarters since. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • EverSource Wealth Advisors held 1,394 shares of Outset Medical worth $6.02K as of Q2 2026.
  • EverSource Wealth Advisors bought 343 Outset Medical shares in Q2 2026, an estimated $1.5K.
  • Outset Medical made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3196 holding.
  • EverSource Wealth Advisors first reported a position in Outset Medical in Q4 2023 and has held it in 7 quarters since.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.